| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 61.889 | 180.750 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 61.889 | 180.750 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 356 | 51.494 | 135.077 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -356 | 10.395 | 45.673 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -356 | 7.687 | 38.365 |
| Employees | - | - | - | - | - | - | - | 1 | 5 | 9 |
Check the financial reports for the company - Alymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 12.782 | 29.144 | 55.997 |
| Current Assets | - | - | - | - | - | - | - | 2 | 22.411 | 33.610 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 15.035 | 2.617 |
| Cash | - | - | - | - | - | - | - | 2 | 7.376 | 30.993 |
| Shareholders Funds | - | - | - | - | - | - | - | -315 | 7.373 | 45.042 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 13.099 | 44.182 | 44.565 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alymed S.r.l.